Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling
Niranjan Awasthi(The University of Texas Southwestern Medical Center), Roderich E. Schwarz(The University of Texas Southwestern Medical Center)
Cited by 65
Related Papers
Inhibition of the MEK/ERK pathway augments nab-paclitaxel-based chemotherapy effects in preclinical models of pancreatic cancer
|Oncotarget|2017|35
Superior Antitumor Activity of Nanoparticle Albumin-Bound Paclitaxel in Experimental Gastric Cancer
|PLoS ONE|2013|33
Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II
|Journal of Experimental & Clinical Cancer Research|2013|30
Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer
|BMC Cancer|2011|26
Targeted dual inhibition of c‐Met/VEGFR2 signalling by foretinib improves antitumour effects of nanoparticle paclitaxel in gastric cancer models
|Journal of Cellular and Molecular Medicine|2021|24